
Jay Bhattacharya
NIH Director and acting CDC Director (March 2025); Stanford health economist; Great Barrington Declaration co-author.
Last refreshed: 17 May 2026 · Appears in 1 active topic
How can one person run both the NIH and CDC while multiple simultaneous PHEICs are active?
Timeline for Jay Bhattacharya
Mentioned in: CDC cuts bird-flu reports to monthly
Pandemics and BiosecurityHeld acting CDC Director role concurrently with NIH Director position during Bundibugyo PHEIC
Pandemics and Biosecurity: Thinnest US health bench faces PHEICWho is Jay Bhattacharya and why is he running both the NIH and CDC?
What is the Great Barrington Declaration and what did Bhattacharya argue?
What is Jay Bhattacharya's plan for pandemic preparedness?
Background
Jay Bhattacharya is a Stanford University health economist and physician who was confirmed as NIH Director in March 2025 and subsequently assumed the acting CDC Director role concurrently. He holds an MD and PhD in economics from Stanford, where he is a professor of health policy. His academic work focuses on the economics of health programmes, healthcare markets and population health measurement.
Bhattacharya became publicly prominent during the COVID-19 pandemic as a co-author of the Great Barrington Declaration (October 2020), a document advocating focused protection of high-risk groups rather than broad population lockdowns and school closures. The declaration attracted significant support from some economists and public-health practitioners and significant criticism from the infectious-disease and epidemiology communities. Its signatories argued that achieving natural immunity in lower-risk populations while shielding the vulnerable would produce better overall outcomes than sustained non-pharmaceutical interventions.
His stated approach to pandemic preparedness was articulated in an X post on 17 January 2024: "The best pandemic preparedness playbook for the United States is making America healthy again." Science-Based Medicine and other commentators characterised the framing as terrain theory — the view that improving baseline population health renders pandemic-response infrastructure less necessary.
Bhattacharya simultaneously holds the NIH Director and acting CDC Director positions during the most complex concurrent outbreak environment of the post-2014 era. In May 2026, the active management load includes a Bundibugyo Ebola PHEIC (17 May), the MV Hondius Andes hantavirus cluster, H5N1 in Idaho dairy cattle surging to 59 quarantined herds, and a UK meningitis B cluster. His acting CDC directorship reportedly expired but he has remained in the role per testimony at the 15 May specialist panel.
On the Ebola outbreak, Bhattacharya stated publicly that the CDC has country offices in DRC and Uganda and is "absolutely committed to providing resources and technical expertise." Africa CDC's 16 May coordination statement names US CDC as a response partner; the WHO AFRO release on outbreak confirmation does not name deployed US CDC field personnel. The practical resource question is not CDC's technical commitment but the absence of the USAID surge infrastructure that embedded deployed staff alongside CDC country-office capacity in 2018.
The combination of the Bhattacharya dual role and the absence of a permanent FDA commissioner and OPHPR head has been characterised by infectious-disease specialists including Nahid Bhadelia and Craig Spencer as the thinnest senior federal public-health leadership bench at the highest concurrent outbreak complexity since 2014. Bhattacharya's own published statement remains the clearest public articulation of his preparedness philosophy: "The best pandemic preparedness playbook for the United States is making America healthy again."